Loss of S100A14 expression is associated with the progression of adenocarcinomas of the small intestine

Pathobiology

Volumn 80, Issue 2, 2012, Pages 95-101

  Kim, Gwangil ^a   Chung, Joon Yong ^b   Jun, Sun Young ^c   Eom, Dae Woon ^d   Bae, Young Kyung ^e   Jang, Kee Taek ^f   Kim, Jihun ^g   Yu, Eunsil ^g   Hong, Seung Mo ^g  

^a CHA University   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Bupyeong gu   (South Korea)

^d University of Ulsan   (South Korea)

^e Yeungnam University College of Medicine   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

Author keywords

Adenocarcinoma; p21; p53; S100A14; Small intestine

Indexed keywords

PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; DUODENUM TUMOR; FEMALE; GENE EXPRESSION; GENE LOSS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; ILEUM TUMOR; IMMUNOHISTOCHEMISTRY; JEJUNUM TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; S100A14 GENE; SMALL INTESTINAL ADENOCARCINOMA; SMALL INTESTINE TUMOR; TISSUE MICROARRAY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPUBLIC OF KOREA; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84866953290     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000342394     Document Type: Article

References (25)

1. Schottenfeld D, Beebe-Dimmer JL, Vigneau FD: The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol 2009; 19: 58-69.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
3. Warth A, Kloor M, Schirmacher P, Blaker H: Genetics and epigenetics of small bowel adenocarcinoma: The interactions of CIN, MSI, and CIMP. Mod Pathol 2011; 24: 564-570.
4. Rondonotti E, Pennazio M, Toth E, Menchen P, Riccioni ME, De Palma GD, Scotto F, De Looze D, Pachofsky T, Tacheci I, Havelund T, Couto G, Trifan A, Kofokotsios A, Cannizzaro R, Perez-Quadrado E, de Franchis R, European Capsule Endoscopy Group, Italian Club for Capsule Endoscopy (CICE), Iberian Group for Capsule Endoscopy: Small-bowel neoplasms in patients undergoing video capsule endoscopy: A multicenter European study. Endoscopy 2008; 40: 488-495.
5. Zouhairi ME, Venner A, Charabaty A, Pishvaian MJ: Small bowel adenocarcinoma. Curr Treat Options Oncol 2008; 9: 388-399.
6. Overman MJ, Pozadzides J, Kopetz S, Wen S, Abbruzzese JL, Wolff RA, Wang H: Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer 2010; 102: 144-150.
7. Delaunoit T, Neczyporenko F, Limburg PJ, Erlichman C: Pathogenesis and risk factors of small bowel adenocarcinoma: A colorectal cancer sibling? Am J Gastroenterol 2005; 100: 703-710. (Pubitemid 40487572)
8. Pietas A, Schluns K, Marenholz I, Schafer BW, Heizmann CW, Petersen I: Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics 2002; 79: 513-522. (Pubitemid 34274292)
9. Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, Hudson L, Poyser HR, Redpath N, Griffiths M, Steers G, Harris AL, Patel S, Berry J, Loader JA, Townsend RR, Daviet L, Legrain P, Parekh R, Terrett JA: Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem 2003; 278: 6482-6489. (Pubitemid 36800908)
10. Chen H, Yu D, Luo A, Tan W, Zhang C, Zhao D, Yang M, Liu J, Lin D, Liu Z: Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma. Cancer Res 2009; 69: 3451-3457.
11. McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ: The role of S100 genes in breast cancer progression. Tumour Biol 2011; 32: 441-450.
12. Ji J, Zhao L, Wang X, Zhou C, Ding F, Su L, Zhang C, Mao X, Wu M, Liu Z: Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004; 130: 480-486. (Pubitemid 39119292)
13. Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN, Cheng L: Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 2007; 27: 3051-3058. (Pubitemid 47607526)
14. Wang HY, Zhang JY, Cui JT, Tan XH, Li WM, Gu J, Lu YY: Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep 2010; 23: 45-52.
15. Sapkota D, Costea DE, Blo M, Bruland O, Lorens JB, Vasstrand EN, Ibrahim SO: S100A14 inhibits proliferation of oral carcinoma derived cells through G1-Arrest. Oral Oncol 2012; 48: 219-225
16. Jin Q, Chen H, Luo A, Ding F, Liu Z: S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE). Plos One 2011; 6:e19375.
17. Winter JM, Ting AH, Vilardell F, Gallmeier E, Baylin SB, Hruban RH, Kern SE, Iacobuzio-Donahue CA: Absence of E-Cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res 2008; 14: 412-418. (Pubitemid 351226108)
18. Arber N, Hibshoosh H, Yasui W, Neugut AI, Hibshoosh A, Yao Y, Sgambato A, Yamamoto H, Shapira I, Rosenman D, Fabian I, Weinstein IB, Tahara E, Holt PR: Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. Cancer Epidemiol Biomarkers Prev 1999; 8: 1101-1105. (Pubitemid 30004908)
19. Salama I, Malone PS, Mihaimeed F, Jones JL: A review of the S100 proteins in cancer. Eur J Surg Oncol 2008; 34: 357-364. (Pubitemid 351381290)
20. Donato R: S100: A multigenic family of calcium-modulated proteins of the ef-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637-668. (Pubitemid 32520962)
21. Chang HK, Yu E, Kim J, Bae YK, Jang KT, Jung ES, Yoon GS, Kim JM, Oh YH, Bae HI, Kim GI, Jung SJ, Gu MJ, Kim JY, Jang KY, Jun SY, Eom DW, Kwon KW, Kang GH, Park JB, Hong S, Lee JS, Park JY, Hong SM: Adenocarcinoma of the small intestine: A multi-institutional study of 197 surgically resected cases. Hum Pathol 2010; 41: 1087-1096.
22. Sapkota D, Bruland O, Costea DE, Haugen H, Vasstrand EN, Ibrahim SO: S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9. Eur J Cancer 2011; 47: 600-610.
23. Wheeler JM, Warren BF, Mortensen NJ, Kim HC, Biddolph SC, Elia G, Beck NE, Williams GT, Shepherd NA, Bateman AC, Bodmer WF: An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 2002; 50: 218-223. (Pubitemid 34087935)
24. Svrcek M, Jourdan F, Sebbagh N, Couvelard A, Chatelain D, Mourra N, Olschwang S, Wendum D, Flejou JF: Immunohistochemical analysis of adenocarcinoma of the small intestine: A tissue microarray study. J Clin Pathol 2003; 56: 898-903. (Pubitemid 37533230)
25. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, O'Hara SM: Global gene expression profiling of circulating tumor cells. Cancer Res 2005; 65: 4993-4997. (Pubitemid 40827303)